Cleerly LABS vs Rapid RV/LV
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if your primary goal is a comprehensive, AI-powered assessment of coronary atherosclerosis and stenosis from CCTA scans. This tool is ideal for detailed plaque characterization, personalized heart disease risk assessment, and tracking disease progression over time to guide long-term management strategies for patients with suspected or known coronary artery disease.
View Cleerly LABS →Choose Rapid RV/LV if…
Choose Rapid RV/LV if you require rapid, automated assessment of pulmonary embolism severity in acute settings. This tool is best suited for emergency departments or critical care units where quickly obtaining objective right and left ventricle ratios from CTPA scans is essential for immediate patient triage and guiding urgent treatment decisions.
View Rapid RV/LV →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | Rapid RV/LV |
|---|---|---|
| Pricing | Varies | Contact vendor for pricing information. |
| Deployment | Cloud, On-premise | On-premises (dedicated server or virtual machine) or hybrid (on-premises/cloud with secure link to cloud), connecting to hospital LAN/firewall. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TieCleerly LABS is a web-based application, which generally offers broad accessibility and ease of use for clinicians, with web search confirming its integration into existing CCTA workflows. Rapid RV/LV, while offering on-premises/hybrid deployment, is praised for its speed and automated measurements that streamline emergency workflows, reducing manual effort. Both are designed to simplify complex tasks within their respective clinical contexts.
Clinical Value
Cleerly LABSCleerly LABS offers a comprehensive and longitudinal assessment of cardiovascular health by providing detailed plaque characterization, stenosis detection, and ischemia detection, aiding in personalized heart disease management and tracking progression over time. Rapid RV/LV provides rapid, objective assessment of pulmonary embolism severity, which is critical for acute care, but Cleerly's broader, proactive approach to disease management offers a deeper and more sustained clinical impact.
Pricing & Value
Cleerly LABSCleerly LABS provides transparent pricing information, including a retail price and a discounted offer, allowing for a clearer understanding of potential costs. In contrast, Rapid RV/LV requires users to contact the vendor for pricing details, making it difficult to assess its value proposition without direct engagement.
Enterprise Readiness
TieBoth tools are FDA-cleared, HIPAA compliant, and offer Business Associate Agreements (BAAs), demonstrating strong foundational enterprise readiness. Cleerly LABS is cloud-based with an on-site proxy for data transfer and integrates with PACS, RIS, and EHR, while Rapid RV/LV offers on-premises or hybrid deployment with integration into its broader Rapid PE solution and triage capabilities. Both deployment models and integration strategies cater to different enterprise IT preferences and needs.
Innovation
Cleerly LABSCleerly LABS demonstrates a higher degree of innovation by focusing on comprehensive AI-powered CCTA analysis for detailed plaque characterization and personalized risk assessment, aiming to redefine heart attack prevention by moving beyond traditional stenosis assessment. Rapid RV/LV, while innovative in its rapid automation of RV/LV ratio measurement for acute PE severity, addresses a more specific diagnostic need rather than a paradigm shift in long-term disease management.
Support & Docs
Rapid RV/LVRapidAI explicitly states it offers 24/7/365 customer support via email and phone for its critical care solutions, indicating a robust and readily available support system. While Cleerly also provides customer support, training, and technical assistance, its stated support hours are Monday through Friday, 10 am ET to 6 pm ET, with after-hours needs as a first priority, which is less comprehensive than RapidAI's round-the-clock availability.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | Rapid RV/LV |
|---|---|---|
| Tool Name | Cleerly LABS | Rapid RV/LV |
| Company | Cleerly | RapidAI (formerly iSchemaView) |
| Primary Clinical Focus | Comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | Rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. |
| Core AI Functionality | AI-powered CCTA image analysis for comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with Cleerly ISCHEMIA module), 3D visualization, personalized heart disease risk assessment, tracking disease progression. | AI-powered analysis of CTPA images for automated measurement of right and left ventricle diameters, calculation of RV/LV ratio, rapid results, reduces inter-rater variability. |
| Target Imaging Modality | Coronary CT angiography (CCTA) | CTPA scans |
| Specialties | Cardiology, Radiology | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and Rapid RV/LV.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or Rapid RV/LV
Backers
Who funded each tool's parent company.